CGM Coverage and Reimbursement

Significant progress has been made for coverage of continuous glucose monitoring (CGM) with both commercial health insurers and government-sponsored plans.

Reimbursement - Commercial Plans

Coverage of CGM for type 1 diabetes is offered for 98% of commercially insured members, and many plans also provide coverage for members with insulin-using type 2 diabetes.*

Learn More

Medicare Reimbursement

Medicare now provides coverage for “therapeutic” CGM systems (those indicated for use in making diabetes treatment decisions without a fingerstick). The Dexcom G5® CGM System is the first therapeutic CGM system covered as a Medicare benefit.

Learn More

*Internal data on file
‡Fingersticks required for calibration of Dexcom G5, or if symptoms or expectations do not match readings, or when taking medications containing acetaminophen.

Contact Dexcom

If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.

If you are a Dexcom User or Patient, please contact Dexcom here.

The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.